GTBIF · Green Thumb Industries Inc.
$6.83
-0.28 (-3.94%)
At close · Jul 28
Market Cap
$1.33B
Shares
195.31M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.18B
+3.4%
FY2025
Net Income
$114.15M
+56.2%
FY2025
Gross Margin
48.91%
-4pp
FY2025
Operating Margin
11.72%
-8pp
FY2025
Diluted EPS
$0.48
+60%
FY2025
Operating Cash Flow
$294.93M
+51.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| $1.2B | $1.18B | $1.14B | $1.05B | $1.02B | $893.56M | $556.57M | |
| $620.68M | $600.4M | $536.03M | $528.06M | $513.41M | $401.63M | $252.4M | |
| $575.26M | $574.89M | $601.11M | $526.5M | $503.96M | $491.93M | $304.17M | |
| — | 48.91% | 52.86% | 49.93% | 49.54% | 55.05% | 54.65% | |
| $439.31M | $437.19M | $376.68M | $341.86M | $294.4M | $277.09M | $198.06M | |
| $49.02M | $49.91M | $50.39M | $50.84M | $59.66M | $45.21M | $37.03M | |
| — | $145.45M | $113.21M | $100.79M | $96.66M | $68.46M | $52.51M | |
| $439.31M | $437.19M | $376.68M | $341.86M | $382.9M | $277.09M | $198.06M | |
| $135.95M | $137.7M | $224.43M | $184.63M | $121.06M | $214.84M | $106.11M | |
| — | 11.72% | 19.74% | 17.51% | 11.9% | 24.04% | 19.06% | |
| — | $283.15M | $337.64M | $285.42M | $217.73M | $283.3M | $158.61M | |
| $20.32M | $20.02M | $24.27M | $19.07M | $21.2M | $21.98M | $18.67M | |
| $150.83M | $125.66M | -$24.29M | -$28.58M | -$12.63M | -$9.87M | -$3.18M | |
| — | — | — | — | — | $0 | — | |
| -$4.23M | -$10.81M | -$8.69M | -$1.17M | -$4.26M | $1.8M | — | |
| — | $29.88M | — | — | — | — | -$56.42K | |
| $286.78M | $263.36M | $200.14M | $156.05M | $108.43M | $204.98M | $102.93M | |
| $164.08M | $147.3M | $126.29M | $118.63M | $94.78M | $124.61M | $83.85M | |
| $121.24M | $114.15M | $73.08M | $36.27M | $11.98M | $75.44M | $14.99M | |
| — | 9.71% | 6.43% | 3.44% | 1.18% | 8.44% | 2.69% | |
| $1.46M | $1.9M | $768K | $1.15M | $1.68M | $4.93M | $4.08M | |
| USD/shares | — | $0.49 | $0.31 | $0.15 | $0.05 | $0.34 | $0.07 |
| USD/shares | — | $0.48 | $0.30 | $0.15 | $0.05 | $0.33 | $0.07 |
| shares | — | 233.87M | 236.83M | 237.93M | 236.71M | 223.19M | 210.99M |
| shares | — | 236.87M | 241.93M | 239.83M | 238.08M | 226.76M | 212.53M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 2.69×
EV/EBIT
—
Peer median 27.74×
P/E (TTM)
17.97×
Peer median 20.56×
Peer medians compare against the 49 similar-size Drug Manufacturers - Specialty & Generic companies (of 91 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Retail Segment | $829,538,000 | $824,726,000 | $791,480,000 | $763,166,000 | $614,739,000 | $396,372,000 | $137,810,000 |
| Consumer Packaged Goods Segment | $677,350,000 | $648,388,000 | $559,480,000 | $495,101,000 | $36,839,000 | $273,977,000 | $109,930,000 |
| Intersegment Eliminations and Corporate | -$331,593,000 | -$335,973,000 | -$296,407,000 | -$240,892,000 | -$188,437,000 | -$113,776,000 | — |